Sleep and Activity Patterns in Depression From Wearable Data: Unsupervised Clustering Study - Report - MDSpire

Sleep and Activity Patterns in Depression From Wearable Data: Unsupervised Clustering Study

  • By

  • Carolin Oetzmann

  • Yuezhou Zhang

  • Nicholas Cummins

  • Ewan Carr

  • Faith Matcham

  • Sara Siddi

  • Femke Lamers

  • Daniel Leightley

  • Katie M White

  • Amos A Folarin

  • Peter Annas

  • Josep Maria Haro

  • Brenda WJH Penninx

  • Srinivasan Vairavan

  • Til Wykes

  • Richard JB Dobson

  • Vaibhav A Narayan

  • Matthew Hotopf

  • June 10, 2026

Share

Clinical Report: Analysis of Sleep and Activity Trends in Depression Using Wearable Technology

Overview

This study employs unsupervised clustering techniques to analyze sleep and activity data from wearable devices in individuals with major depressive disorder (MDD). It identifies distinct subtypes of depression based on objective data, revealing variability in symptom manifestation and potential pathways for personalized interventions.

Background

Depression is a prevalent mental health condition that significantly impacts daily functioning and quality of life. Traditional assessment methods often rely on subjective self-reports, which can introduce biases and variability. The integration of wearable technology and digital phenotyping offers an opportunity to gather objective, real-time data on sleep and activity patterns, which are critical components of depression symptomatology.

Data Highlights

This study analyzed data from 623 participants diagnosed with recurrent MDD, utilizing wearable technology to collect continuous sleep and activity metrics.

Key Findings

  • Unsupervised clustering revealed distinct subtypes of depression based on sleep and activity patterns.
  • Participants exhibited variability in physical activity levels, with some showing lower overall movement compared to controls.
  • Sleep disturbances were identified as both markers and risk factors for depression, with diverse dysregulation profiles observed.
  • Higher nighttime activity was noted in clinical groups, suggesting unique behavioral patterns associated with depression.
  • Transition between identified subtypes over time indicates dynamic changes in depression states.

Clinical Implications

The findings suggest that wearable technology can enhance the understanding of depression by providing objective data that may inform personalized treatment strategies. Clinicians should consider integrating digital phenotyping into routine assessments to better monitor and address individual patient needs.

Conclusion

This study highlights the potential of wearable technology in identifying subtypes of depression, which may lead to more tailored and effective interventions. Further research is needed to validate these findings and explore their clinical applications.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. BMC Psychiatry (Springer) -- Network analysis of interrelationships among physical activity, sleep disturbances, depression, and anxiety in college students
  3. Frontiers in Psychiatry -- Prospective observational study on behavioral monitoring, disease progression assessment, and screening model development for patients with depression using wearable devices and mobile phones: protocol
  4. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults
  5. January 2026 exceptional surveillance of depression in adults: treatment and management (NICE guideline NG222)
  6. npj Digital Medicine — Personalised modelling of routine variability and affective states
  7. Actigraphic monitoring of sleep and circadian rest-activity rhythm in individuals with major depressive disorder or depressive symptoms: A meta-analysis
  8. Digital phenotyping for predicting relapse in psychiatric disorders: a systematic review of passive sensing approaches
  9. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes
  10. January 2026 exceptional surveillance of depression in adults: treatment and management (NICE guideline NG222)
  11. Psychiatry.org - The App Evaluation Model
  12. Journal of Aϱective Disorders 363 (2024 ) 90–98
  13. Digital phenotyping and digital monitoring technologies for relapse detection in mental health: a systematic review | BMC Psychiatry | Springer Nature Link
  14. Staying current with actigraphy devices for sleep-wake monitoring - American Academy of Sleep Medicine – Association for Sleep Clinicians and Researchers
  15. Evaluating reliability in wearable devices for sleep staging | npj Digital Medicine
  16. Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders (CDDR)

Original Source(s)

Related Content